Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aquaderm is a topical dermatological formulation designed to alleviate symptoms of dry, rough, and scaly skin conditions such as xerosis, ichthyosis, and various forms of dermatitis. The product typically functions as a combination of humectants and emollients. Its primary active components often include urea and lactic acid, which act as keratolytics and humectants by increasing the water-binding capacity of the stratum corneum and promoting the shedding of dead skin cells. Additionally, ingredients like liquid paraffin and propylene glycol serve as emollients and occlusives, forming a protective barrier on the skin's surface to trap moisture and prevent transepidermal water loss. This synergistic approach helps to restore the skin's natural lipid barrier and improve overall skin texture and hydration.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Aquaderm.